Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis
Clinical trials of new drugs for the treatment of rheumatoid arthritis
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses’ Health Study II
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
A psychometric analysis of outcome measures in peripheral spondyloarthritis
Patients with chronic back pain of short duration from the SPACE cohort
Statin use and mortality in rheumatoid arthritis
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis
A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate
Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus
Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment
Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis
Whole-genome single nucleotide polymorphism-based linkage analysis in spondyloarthritis multiplex families reveals a new susceptibility locus in 13q13
MICL controls inflammation in rheumatoid arthritis
Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms
Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Replication of a distinct psoriatic arthritis risk variant at the IL23R locus
Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis
Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis
Evidence for treating rheumatoid arthritis to target
Response to
Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept
Response to
Anti Etanercept and anti SB4 antibodies detection
Confirmation on the immunogenicity assay used in the SB4 phase III study
Low dose of fish oil in osteoarthritis
Fish oil for OA? Don't give up yet
Did the subjects and the controls have the same disease?
Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
Can genetics explain the higher risk of worsening knee pain in offspring of people with total knee replacement for severe primary knee osteoarthritis?